The effect of 1.25 dihydroxyvitamin D3 on binding and internalization of epidermal growth factor in cultured cells
- 1 October 1989
- journal article
- research article
- Published by Elsevier in Experimental Cell Research
- Vol. 184 (2) , 329-341
- https://doi.org/10.1016/0014-4827(89)90332-7
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- In vitro study of effects of 1,25 dihydroxyvitamin D3 on the morphology of human breast cancer cell line BT.20Differentiation, 1989
- Direct visualization of the phosphorylated epidermal growth factor receptor during its internalization in A-431 cells.The Journal of cell biology, 1987
- 1,25-dihydroxyvitamin D3 inhibits the clonogenic growth of transformed cells via its receptorBiochemical and Biophysical Research Communications, 1986
- 1,25-Dihydroxyvitamin D3 inhibitory effect on the growth of two human breast cancer cell lines (MCF-7, BT-20)Journal of Steroid Biochemistry, 1986
- Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cellsNature, 1984
- The Vitamin D Endocrine System: Steroid Metabolism, Hormone Receptors, and Biological Response (Calcium Binding Proteins)*Endocrine Reviews, 1982
- Epidermal growth factor induces rapid tyrosine phosphorylation of proteins in A431 human tumor cellsCell, 1981
- 1,25-DIHYDROXYVITAMIN D3AND MALIGNANT MELANOMA: THE PRESENCE OF RECEPTORS AND INHIBITION OF CELL GROWTH IN CULTUREEndocrinology, 1981
- 1,25-DIHYDROXYVITAMIN-D RECEPTOR IN BREAST CANCER CELLSThe Lancet, 1979
- Epidermal Growth FactorAnnual Review of Biochemistry, 1979